| scholarly article | Q13442814 |
| P2093 | author name string | Ming Zhang | |
| Fei Chen | |||
| Xin Su | |||
| Yi Shi | |||
| Xiao-Yong Xu | |||
| Wen-Kui Sun | |||
| P2860 | cites work | In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus. | Q50943987 |
| The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. | Q51191763 | ||
| Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis | Q56993324 | ||
| Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America | Q28263689 | ||
| Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus | Q33857685 | ||
| Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis | Q34641443 | ||
| Efficacy of micafungin alone or in combination against systemic murine aspergillosis | Q34884594 | ||
| Clinical pharmacokinetics of voriconazole. | Q36431010 | ||
| In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus | Q36492208 | ||
| The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications | Q36626518 | ||
| Pulmonary aspergillosis: a clinical update | Q36831494 | ||
| Fungal infections in hematopoietic stem cell transplant recipients | Q37139544 | ||
| Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin | Q37190801 | ||
| Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis | Q37204192 | ||
| Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside | Q37578647 | ||
| Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis? | Q37859397 | ||
| Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis | Q39652561 | ||
| Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification | Q39900331 | ||
| Efficacy of PTX3 in a rat model of invasive aspergillosis | Q42102175 | ||
| Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. | Q42286250 | ||
| Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin | Q44469440 | ||
| Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus | Q44619968 | ||
| Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis | Q46868249 | ||
| Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study | Q46943408 | ||
| Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis | Q46971553 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1-2 | |
| P921 | main subject | aspergillosis | Q259626 |
| voriconazole | Q412236 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 11-18 | |
| P577 | publication date | 2013-12-06 | |
| P1433 | published in | Mycopathologia | Q15763210 |
| P1476 | title | Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species | |
| P478 | volume | 177 |
| Q52597960 | A novel polyaminocarboxylate compound to treat murine pulmonary aspergillosis by interfering with zinc metabolism. |
| Q40617936 | Administration of Zinc Chelators Improves Survival of Mice Infected with Aspergillus fumigatus both in Monotherapy and in Combination with Caspofungin |
| Q34094024 | Antifungal and Antioxidant Activities of the Essential Oil from Angelica koreana Nakai |
| Q46290055 | Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations |
| Q55471038 | Diagnostic Aspects of Veterinary and Human Aspergillosis. |
| Q48179374 | In Vitro Combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp. |
| Q42204971 | In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei |
| Q57705351 | Recent Advancements in Combinational Antifungal Therapy and Immunotherapy |
| Q92859582 | Resistance mechanism and proteins in Aspergillus species against antifungal agents |
| Q33689767 | Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization. |
Search more.